Despite earning its reputation as one of medicine's most formidable challenges, pancreatic cancer is no longer the sole story. A subset of patients can be cured with surgery. Survival is extending with better systemic therapies. Precision oncology is beginning to identify actionable molecular targets in a cancer once thought to have none.
The pancreas sits behind the stomach, performing two vital functions: producing digestive enzymes and secreting hormones. We treat all forms, including Pancreatic ductal adenocarcinoma (PDAC), neuroendocrine tumors (NETs), and cystic neoplasms.
Paradoxically, pancreatic head tumors often cause jaundice early, increasing the likelihood of finding them at a resectable stage. Body and tail tumors remain silent far longer.
Painless, progressive yellowing of skin and whites of eyes.
Persistent upper abdominal pain radiating through to the back.
Rapid, unexplained weight loss or severe loss of appetite.
New-onset diabetes without risk factors or sudden worsening.
Accurate staging is critical for pancreatic cancer to determine whether the tumor can be surgically removed.
Evaluates tumour size, vessel contact, and metastases.
Superior for bile duct involvement and cystic lesion evaluation.
Tissue confirmation and detailed local staging via ultrasound.
Identifies occult distant metastases before surgery.
Our multidisciplinary tumour board provides rapid review for all pancreatic cancer cases to formulate a personalized treatment plan.
Among the most complex abdominal surgeries, performed through small incisions with exceptional robotic precision, reducing blood loss and hospital stay.
For cancers in the body or tail, achieves radical lymphadenectomy and vessel dissection with precision for long-term survival.
Chemotherapy or PARP inhibitors (for BRCA mutations) used to shrink tumors before surgery or extend survival significantly.
Call Now
